GPhC chair among pharmacists celebrated in King’s Birthday Honours Gisela Abbam, chair of the General Pharmaceutical Council, has been recognised for her services to pharmacy.…
The Critical Medicines Act: can the UK manage supply problems with the EU’s ‘safety belt’? Pharmacy leaders are hopeful that the Critical Medicines Act will help to alleviate medicines shortages in the UK, which have been rumbling on for several years.…
NICE approves seladelpar for primary biliary cholangitis Around 3,700 people in England will be eligible to receive a new treatment that could delay progression of primary biliary cholangitis and reduce itching.…
PDA warns of ‘concerning’ decline in community pharmacists per pharmacy The number of full-time equivalent pharmacists working in community pharmacy has reduced from 20,255 in 2021 to 17,415 in 2025, a PDA report says.…
Pharmacy minister praises ‘strategic thinking’ on community pharmacy reform Speaking at a Westminster Hall debate, Stephen Kinnock thanked Community Pharmacy England for its "constructive engagement" on long term reform of community pharmacy.…
Tezepelumab may reduce need for oral corticosteroids in severe asthma Study authors said their results “show the potential of tezepelumab to reduce maintenance oral corticosteroid use while maintaining asthma control and without compromising the efficacy outcomes”.…
Selective NSAIDs reduce risk of GI bleeding, study suggests Researchers observed that when COX-2-selective non-steroidal anti-inflammatory drugs were used with direct-acting oral anticoagulants for nonvalvular atrial fibrillation, the risk of gastrointestinal bleeding decreased by more than one-third.…
NHS-funded community independent prescribing announced as part of pharmacy contract Under the ‘Community pharmacy contractual framework’ for 2026/2027, the Department of Health and Social Care said pharmacists with independent prescribing qualifications will be able to “assess patients and prescribe medicines directly”.…
NICE approves add-on treatment for uncontrolled COPD Clinical trial evidence suggests that mepolizumab plus triple therapy reduces the number of moderate or severe exacerbations associated with uncontrolled chronic obstructive pulmonary disease.…
Government medicines manufacturing training scheme used by more than 2,000 people so far The RESILIENCE programme has been developed to provide training for people in the medicines manufacturing sector.…
